We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

158 hedge funds and large institutions have $309M invested in BioDelivery Sciences International, Inc. in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 40 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $485K | Put options by funds: $238K

48% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 40

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

18% more capital invested

Capital invested by funds: $263M → $309M (+$46.4M)

3% more funds holding

Funds holding: 153158 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
158
Holders Change
+5
Holders Change %
+3.27%
% of All Funds
3.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
59
Reduced
40
Closed
19
Calls
$485K
Puts
$238K
Net Calls
+$247K
Net Calls Change
+$865K
Name Holding Trade Value Shares
Change
Change in
Stake
Daiwa Securities Group
151
Daiwa Securities Group
Japan
$2K
IA
152
IFP Advisors
Florida
$2K
PWMG
153
Prestige Wealth Management Group
New Jersey
$2K
AW
154
Avion Wealth
Texas
$1K
US Bancorp
155
US Bancorp
Minnesota
$1K
GWM
156
Geneos Wealth Management
Colorado
$1K +$1.57K +350 New
BBA
157
Baker Bros. Advisors
New York
-$6.21M -1,638,334 Closed
GPGA
158
Grandeur Peak Global Advisors
Utah
-$6.04M -1,593,949 Closed
SCM
159
Stonepine Capital Management
Oregon
-$2.86M -755,000 Closed
DCM
160
DG Capital Management
New York
-$1.23M -323,330 Closed
JGC
161
J. Goldman & Co
New York
-$438K -115,550 Closed
DCM
162
Driehaus Capital Management
Illinois
-$265K -70,000 Closed
Millennium Management
163
Millennium Management
New York
-$203K -53,661 Closed
CI
164
Cavalier Investments
Georgia
-$201K -53,000 Closed
Wolverine Trading
165
Wolverine Trading
Illinois
-$145K -38,798 Closed
SSA
166
Schonfeld Strategic Advisors
New York
-$136K -35,992 Closed
State of Tennessee, Department of Treasury
167
State of Tennessee, Department of Treasury
Tennessee
-$130K -34,175 Closed
LI
168
Leap Investments
Illinois
-$82K -21,700 Closed
JCM
169
JS Capital Management
New York
-$82K -21,600 Closed
LPL Financial
170
LPL Financial
California
-$76K -20,023 Closed
Walleye Trading
171
Walleye Trading
New York
-$68K -17,885 Closed
ZCM
172
Zebra Capital Management
Connecticut
-$63K -16,693 Closed
HF
173
HRT Financial
New York
-$61K -16,320 Closed
NIT
174
NumerixS Investment Technologies
British Columbia, Canada
-$31K -8,300 Closed
Group One Trading
175
Group One Trading
Illinois
-$18.5K -4,120 Closed

BDSI Hedge Fund Activity: Q2 2020 in Review

158 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2020, worth a combined $309M — up 18% from $263M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new BDSI positions and 19 closed out — a net gain of 7 holders — while 59 added to existing stakes and 40 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.72M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $6.21M sold.

  • 158 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2020, up from 153 in Q1 2020.
  • Funds reported $309M of BioDelivery Sciences International, Inc. stock for Q2 2020, up 18% quarter-over-quarter.
  • 26 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2020 and 19 closed out, a net change of +7 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q2 2020 was Vanguard Group, an estimated $3.72M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2020 was Baker Bros. Advisors, an estimated $6.21M sold.

Based on aggregated 13F filings for Q2 2020.